
NeuroSpring is a 501(c)(3) public charity dedicated to developing innovative medical therapies for significant global healthcare challenges, including stroke, epilepsy, and traumatic brain injuries. They engineer medical devices and treatments at the intersection of mind and machine. Their current projects include the Artificial Intelligence Diagnostic Project (Virtual Neurologist), Facial Nerve Stimulation Project, and the TeleSpring initiative to connect neurologists with underserved communities. NeuroSpring also focuses on training the next generation of scientists and engineers through their internship programs. They have achieved Platinum certification from GuideStar and four-star certification from Charity Navigator, with over 96% of funding directed to research and internships.

NeuroSpring is a 501(c)(3) public charity dedicated to developing innovative medical therapies for significant global healthcare challenges, including stroke, epilepsy, and traumatic brain injuries. They engineer medical devices and treatments at the intersection of mind and machine. Their current projects include the Artificial Intelligence Diagnostic Project (Virtual Neurologist), Facial Nerve Stimulation Project, and the TeleSpring initiative to connect neurologists with underserved communities. NeuroSpring also focuses on training the next generation of scientists and engineers through their internship programs. They have achieved Platinum certification from GuideStar and four-star certification from Charity Navigator, with over 96% of funding directed to research and internships.
Product: Virtual Neurologist — AI-enabled system to identify neurological emergencies in ambulances and emergency departments
Affiliation: Referenced as a collaboration partner with NeuroSpring
Public visibility: Presented at Alchemist Accelerator Demo Day (Sept 17, 2020) per TechCrunch listing
Founders: No founder information available in the provided evidence
Neurology emergency diagnosis; pre-hospital and emergency department triage for stroke, seizures, and other acute neurological events.
Biotechnology